Navigation Links
CMSI produces Low cost Anti-retroviral drugs in India

Comprehensive Medical Services India (CMSI) has produced two Anti-retrovirals which can be used in the treatment of HIV/AIDS. The two drugs Nevirapine and Zidovudine is produced by CMSI in its // manufacturing unit in Chennai, India. These two drugs were officially released by Sebastian Ouseperamppil, Director-general, Catholic Health Association. A new microbiology department which could maintain the quality control and Research facilities was dedicated to this manufacturing unit.

The two drugs, Nevirapine and Zidovudine, manufactured by the Essential Drug project of the CMSI, are now available at “reasonable” rates. The organization will soon make available the other components of the ARV tri-drug therapy: Lamivudine, Efaravenz and Combinations of Lamivudine, Stavudine and Nevirapine in various strengths, said CMSI executive trustee-director Moses P. Manohar. Jane Masiga, from the Mission for Essential Drugs and Supplies, Nairobi, Kenya, received the first consignment of Zidovudine capsules from Bimal Charles, Epidemiologist, Center for Disease Control.

Dr. Charles of Center for Disease Control said that the company should maintain the quality of the drugs without compromising on the cost of the drug by maintaining strict quality control measures. He said that the AIDS drugs which was very expensive and is less affordable by economically weaker section has become cheaper and could be affordably brought by the patients.
'"/>




Page: 1

Related medicine news :

1. Five AIDS Patients To Receive Experimental Anti-retroviral Drugs
2. Anti-retroviral drug conserving trial halted
3. One Lakh HIV Patients to get Free Anti-retroviral Drugs by 2007
4. Mental Illness Reversed with Anti-retrovirals in HIV Cases
5. Cancer drugs in development nearly doubled since 1995
6. Cipla holds talks with mining giant to supply AIDS drugs for South African workers
7. African HIV strains more resistant to anti HIV drugs
8. Right drugs drastically cut stroke risk
9. Relating heart protection and antihypertensive drugs
10. Enzyme may be target for obesity drugs
11. New HIV cases resist drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... , ... April 24, 2017 , ... My T Chai, ... its products are now available for purchase on RevNutrition.com, a popular website specializing in ... first produced and popularized in ancient India and Siam. It spread across Asia and ...
(Date:4/24/2017)... ... April 24, 2017 , ... symplrTM, a leading ... today announced that Kyle Allain has joined the company as Vice President and ... operations, including provider, payor and managed care solutions. , A seasoned executive ...
(Date:4/24/2017)... ... 24, 2017 , ... In 2017, up to 78,000 new ... of them will be malignant.(1) As research into precision medicine continues, both patients ... in the diagnosis and treatment of brain tumors. Healthcare facilities that are already ...
(Date:4/24/2017)... ... 2017 , ... Rod Burkett, CEO of Gardant Management Solutions, was recently featured ... at the forefront of Gardant since it was founded in 1999. His drive and ... of more than 40 new senior living communities. With his leadership, Gardant has grown ...
(Date:4/24/2017)... ... ... As a former supermodel known for her timeless beauty, Joan Severance knows ... is that she put all the words in her new book, "Manifest Your Mate: ... and sparkling sense of humor have inspired her to write a book on how ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global ... and Gynecology markets with innovative and proprietary products, will ... 31, 2017 after the market close on Tuesday, May ... a conference call and webcast to discuss its financial ... at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). ...
(Date:4/18/2017)...  Astute Medical, Inc., developer of biomarkers for better ... at the 2017 National Kidney Foundation (NKF) Spring ... April 22. Physicians will present data on two biomarkers, ... for acute kidney injury (AKI) during the management of ... Elevated levels of TIMP-2 and IGFBP-7 have been ...
Breaking Medicine Technology: